Immunotherapy for pancreatic cancer - science driving clinical progress.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15905855.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The identification of key signalling pathways involved in immune-system regulation, along with the development of early pancreatic tumours in mouse models have provided new opportunities for pancreatic cancer treatment and prevention. Immunotherapy for pancreatic cancer is one approach that is at a crucial crossroads, as therapeutics that are designed to target pancreatic-cancer-associated antigens and regulatory signalling molecules are entering clinical trials.
Medical subject headings
- Antigens, Neoplasm
- Cancer Vaccines
- Immunotherapy
- Pancreatic Neoplasms